Edward Rebar
Chief Scientific Officer CPTx
Seminars
Wednesday 2nd December 2026
Advancing In Vivo DNA Delivery Platforms to Enable Durable & Controllable Immune Reset
11:30 am
- Evaluating DNA-based delivery approaches against RNA and viral systems to achieve more sustained yet controllable immune cell modification for autoimmune applications
- Exploring strategies to balance transient versus integrating expression to optimize durability while minimizing long-term safety concerns
- Leveraging complex cargo design including multi-target and dual CAR approaches to address immune reset alongside disease-specific drivers such as fibrosis
